90 FR 54 pg. 13378 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Type: NOTICEVolume: 90Number: 54Page: 13378
Page: 13378FR document: [FR Doc. 2025-04826 Filed 3-20-25; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK High Impact Interdisciplinary Science RC2.
Date: April 22, 2025.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Peter J. Kozel, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, MSC5453, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 594-4721, Kozelp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)
Dated: March 17, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-04826 Filed 3-20-25; 8:45 am]
BILLING CODE 4140-01-P